PUBLIC COMPANY
save$IMNMImmunome Inc.
$IMNM20.90+0.05%Bothell, WA, USupdated 18h ago
The immunome is the set of genes that code for proteins which constitute the immune system, excluding those that are widespread in other cell types, and not involved in the immune response itself. It is further defined as the set of peptides derived from the proteome that interact with the immune system. There are numerous ongoing efforts to characterize and sequence the immunomes of humans, mice, and elements of non-human primates.
community read0 votes
pipeline
3
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Phase 11Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →🐶 Hiring Signal
News
- Argenx jumps on Phase 3 data for blockbuster VyvgartThe latest results give investors confidence in the drug's ability to be approved in another indication for which there are no approved treatments.biopharma_dive · 1mo ago
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that